A clinical study showed that statins treatment before stroke could decrease the levels of pro-inflammatory factors after stroke, and RhoA GTPase as well as its downstream effectors might be the targets for statins to exert anti-inflammatory effects (Schultz et al., 2019). This evidence concerns the gene RHOA and stroke disorder.